Methronidazole

Also known as: Metronidazole

Active ingredient description

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Metronidazole
A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment
Discover more medicines within A01AB17
Metronidazole
D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BX Other chemotherapeutics
Discover more medicines within D06BX01
Metronidazole
G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF01
Metronidazole
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD01
Metronidazole
P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01A Agents against amoebiasis and other protozoal diseases → P01AB Nitroimidazole derivatives
Discover more medicines within P01AB01

Medicines

Methronidazole is the active ingredient of these drugs:

Drug
Countries

United Kingdom

South Africa

South Africa

South Africa

Cyprus United Kingdom

Austria

South Africa

Tunisia

Germany Lithuania Poland

South Africa

South Africa

Hong Kong

Brazil

Cyprus New Zealand

Cyprus

South Africa

Hong Kong

Lithuania

Brazil

Hong Kong

Hong Kong

Brazil

Australia Brazil Canada Cyprus Finland

Cyprus

South Africa

Hong Kong

Hong Kong

France Poland

Brazil

Brazil

Cyprus Hong Kong

Singapore

Brazil

Hong Kong

South Africa

South Africa

Hong Kong

South Africa

Singapore South Africa

United States

Canada South Africa United Kingdom United States

Australia Hong Kong New Zealand Tunisia

Tunisia

United States

Brazil

Australia

Brazil

Hong Kong

Lithuania Netherlands United Kingdom

Ireland

Hong Kong

South Africa

South Africa

Brazil

Canada

Cyprus

South Africa

Austria

Brazil

Hong Kong Singapore

Canada United States

South Africa

United States

Tunisia

United States

Hong Kong

Finland

Netherlands United Kingdom

France

Poland

Austria Brazil Finland France Hong Kong

Lithuania

Hong Kong

Tunisia

Hong Kong

Hong Kong

Hong Kong

Lithuania

New Zealand

Finland

Singapore

Brazil

Hong Kong

Italy Tunisia

United States

Finland United Kingdom

United Kingdom

Methronidazole is also found within below combination drugs:

BI-MISSILOR , BI-SPIRAZOL , BI-SPIROGYL , BIO-VAGIN , BIOGYL , BIRODOGYL , COLPATRIN , COLPIST MT , COLPISTAR , COLPISTATIN , ENTAMIZOLE , FLAGYL COMP , FLAGYL NISTATINA , FLAGYSTATIN , GYNALGIN , GYNOTRAN , HELIPAK A , KLION-D , KOLPITRAT , MECLON , OGYL , PYLERA , RHODOGIL , RODOGYL , SPIRAMIZOLE , SPIRAZOL , SPIROGYL , TERGYNAN , TRICOMAX

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

140QMO216E - METRONIDAZOLE

CAS registry number

13182-89-3 - Metronidazole benzoate

443-48-1 - metronidazole

SNOMED-CT

372602008 - Metronidazole (substance)